Find clinical trials for prurigo nodularis. Search for prurigo nodularis clinical trials in different cities and states across the United States.
Clinical trials for prurigo nodularis (PN) are research studies designed to evaluate new and existing treatments, procedures, or interventions aimed at improving the management of this chronic skin condition. These trials aim to investigate the efficacy, safety, and tolerability of various therapies, including medications, topical treatments, lifestyle interventions, and surgical procedures, with the ultimate goal of advancing the understanding and treatment of PN.
PN clinical trials play a crucial role in advancing the field of dermatology and addressing the unmet needs of patients with prurigo nodularis. By testing new treatments and diagnostic approaches, these studies contribute to expanding the available options for patients, potentially offering more effective therapies with fewer side effects. Additionally, participating in clinical trials can provide patients with access to cutting-edge treatments that may not be available through standard care, offering hope for improved outcomes and symptom management.
Clinical trials for prurigo nodularis encompass a range of study types, each focusing on different aspects of the condition and treatment strategies. These trials explore various approaches to managing and treating PN, aiming to improve understanding and develop effective therapies tailored to the needs of patients.
These trials aim to assess the effectiveness of newly developed medications, topical treatments, or medical procedures in managing the symptoms of prurigo nodularis and ultimately improving the outcomes for patients. Researchers carefully evaluate how these interventions impact the severity and frequency of PN symptoms, such as itching and the formation of nodules, as well as their overall impact on patient well-being and quality of life.
Diagnostic Studies concentrate on improving diagnostic tools and techniques to accurately identify prurigo nodularis and differentiate it from other skin conditions. By enhancing diagnostic accuracy, healthcare providers can ensure timely and precise diagnosis, leading to more effective management of PN.
These trials investigate strategies aimed at preventing the onset or recurrence of PN symptoms. This may include exploring lifestyle modifications, such as changes in diet or exercise, as well as early intervention approaches designed to address underlying factors contributing to the development of prurigo nodularis. The goal is to identify effective preventive measures that can reduce the burden of PN and improve long-term outcomes for individuals at risk.
Quality of life studies focus on interventions designed to enhance the overall well-being and quality of life of individuals living with prurigo nodularis. These studies may include psychosocial support programs, symptom management strategies, or other interventions designed to address the physical, emotional, and social aspects of living with PN.
Interested in learning more about prurigo nodularis (PN)? Dive into our comprehensive guide to discover insights into this condition's nature, its symptoms, potential causes, and more!
Participation in prurigo nodularis clinical trials typically involves individuals who have been diagnosed with the condition and meet specific eligibility criteria outlined by the trial protocol. Criteria may include factors such as age, disease severity, treatment history, and overall health status. Informed consent is required from all participants, and some trials may have additional requirements or restrictions.
Participants in Prurigo Nodularis clinical trials can expect to undergo a thorough screening process to determine eligibility. If accepted into the trial, they will receive the assigned intervention, whether it be a new treatment, diagnostic test, or preventive measure. Throughout the trial, participants will be closely monitored for changes in symptoms, side effects, and treatment efficacy. Regular follow-up visits and assessments are typically conducted to track progress. Close communication with healthcare providers and trial investigators is essential throughout the trial process to ensure the safety and well-being of participants and the integrity of the study results.
Enrolling in a clinical trial for prurigo nodularis through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
Incyte Corporation
Location:
Code:
NCT06213831
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib Cream 1.5%
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516965
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
Sponsor:
Amgen
Location:
Code:
NCT06527404
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Rocatinlimab
Placebo
Sponsor:
Celldex Therapeutics
Location:
Code:
NCT06366750
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
barzolvolimab
Matching Placebo
Sponsor:
Incyte Corporation
Location:
Code:
NCT05755438
Conditions
Prurigo
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib Cream
Vehicle Cream
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516952
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
Sponsor:
Sanofi
Location:
Code:
NCT06293053
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Sponsor:
Incyte Corporation
Location:
Code:
NCT05764161
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib Cream
Vehicle Cream